Jun 2026 (Q2 FY26) — Aug 11, 2026
Evolv Technology Q2 FY26 — Strong Revenue Growth and Expanded Profitability
Read the full callEvolv Technology (EVLV) earnings
- Jun 2026
- Jun 2026 (Q2 FY26)
- Dec 2025
Evolv Technology earnings: last reported Tue, 11 Aug 2026, for the quarter ended Jun 2026.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 43.8 | +34.4% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | -24.1 | +29.6 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | -9.3 | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. The year-earlier figure was zero or a loss, so no percentage is shown. |
Price
$4.18 +3.21% · +$0.13
Performance −49.6% 1Y
1Y: $8.3 on 14 Oct 2025 → $4.18. High $8.3 (14 Oct 2025), low $4.05 (14 Oct 2026).
- Previous close
- $4.05
- 52-week range
- $4.05 – $8.3
- One year
- −49.39%
Overview
- Symbol
- EVLV
- Sector
- Industrials
- Exchange
- US
- Currency
- USD
Call summaries
Every analysed call
Evolv Technology earnings calls (EVLV)
Financials
What the filings say
Net profit, year on year: +77% (quarter to jun 2026 against jun 2025).
| Line item | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 27 | 29 | 32 | 33 | 43 | 39 | 46 | 44 |
| Operating profit | -19 | -19 | -14 | -17 | -9 | -8 | -8 | -11 |
| Operating margin | −70.0% | −64.9% | −45.0% | −53.8% | −20.1% | −20.7% | −18.3% | −24.1% |
| Other income | -11 | 3 | 13 | -23 | 7 | 19 | 3 | 1 |
| Interest | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 1 |
| Profit before tax | -30 | -16 | -2 | -41 | -2 | 11 | -5 | -9 |
| Tax rate | 0.0% | 0.0% | −3.9% | 0.0% | 0.0% | 0.0% | 0.7% | 0.0% |
| Net profit | -30 | -16 | -2 | -41 | -2 | 11 | -5 | -9 |
| EPS ($ per share) | -0.19 | — | -0.01 | -0.25 | -0.01 | — | -0.03 | -0.05 |
| Line item | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Equity capital | 76 | 0 | 0 | 0 | 0 | 0 |
| Reserves | -95 | -106 | -193 | -301 | -355 | -388 |
| Total liabilities | 31 | 73 | 118 | 153 | 150 | 185 |
| Fixed assets | 10 | 24 | 45 | 113 | 124 | 128 |
| Investments | — | — | 0 | 51 | 15 | — |
| Total assets | 22 | 363 | 344 | 297 | 268 | 304 |
| Line item | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | Dec 2025 |
|---|---|---|---|---|---|---|
| Cash from operations | -24 | -57 | -75 | -10 | -31 | 19 |
| Cash from investing | -6 | -18 | -24 | -123 | -1 | -42 |
| Cash from financing | 17 | 378 | 21 | -30 | 2 | 35 |
| Net cash flow | -13 | 303 | -78 | -163 | -30 | 12 |
| Capital expenditure | -6 | -17 | — | — | — | — |
| Free cash flow | -30 | -73 | — | — | — | — |
Insider filings
65 filings between Oct 24, 2025 and Sep 4, 2026.
Open market
decisions to buy or sellPurchases
$749.5K
12 purchases by 6 insiders
Sales
$9.87M
19 sales by 5 insiders
74% filed under a 10b5-1 plan — scheduled in advance, not decided on the day
Compensation
not trading decisions- 31
- Option exercise — converted options into shares
Also filed: 3 dispositions to the issuer.
Who traded
open market only| Insider | Bought | Sold | Last filing |
|---|---|---|---|
| Ellenbogen Michael | — | $5.26M | Aug 17, 2026 |
| Chitkara Anil | — | $3.28M | Mar 2, 2026 |
| Kedzierski John | $47.3K | $522.5K | Jan 5, 2026 |
| Marshall Robert E | $42.4K | $425.2K | Jun 2, 2026 |
| Shapiro Richard A | $439.9K | — | Sep 4, 2026 |
| Kutsor George C | — | $374.0K | May 4, 2026 |
| Kuhl Henrik | $86.0K | — | Aug 14, 2026 |
| Charlton Kevin M. | $85.2K | — | Nov 21, 2025 |
Latest filings (50)
| Date | Insider | What | Shares | Value |
|---|---|---|---|---|
| Sep 4, 2026 | Shapiro Richard A Director | Purchase | 3,600 | $17.8K |
| Sep 4, 2026 | Shapiro Richard A Director | Purchase | 13,500 | $67.0K |
| Sep 4, 2026 | Shapiro Richard A Director | Purchase | 6,500 | $32.2K |
| Sep 4, 2026 | Shapiro Richard A Director | Purchase | 9,000 | $44.8K |
| Aug 17, 2026 | Ellenbogen Michael Director | Sale 10b5-1 plan | 80,752 | $451.4K |
| Aug 17, 2026 | Ellenbogen Michael Director | Option exercise 10b5-1 plan | 80,752 | $19.4K |
| Aug 14, 2026 | Glat Neil Director | Purchase | 8,500 | $48.8K |
| Aug 14, 2026 | Kuhl Henrik Director | Purchase | 15,000 | $86.0K |
| Jul 16, 2026 | Glat Neil Director | Disposition to issuer | 15,091 | $0 |
| Jul 16, 2026 | Charlton Kevin M. Director | Disposition to issuer | 67,500 | $0 |
| Jul 16, 2026 | Glat Neil Director | Disposition to issuer | 17,500 | $0 |
| Jul 15, 2026 | Ellenbogen Michael Director | Option exercise 10b5-1 plan | 80,745 | $19.4K |
| Jul 15, 2026 | Ellenbogen Michael Director | Sale 10b5-1 plan | 80,745 | $479.6K |
| Jun 17, 2026 | Kuhl Henrik Director | Option exercise | 9,291 | $0 |
| Jun 17, 2026 | Charlton Kevin M. Director | Option exercise | 27,050 | $0 |
| Jun 17, 2026 | Sheehy Kimberly H. Director | Option exercise | 27,050 | $0 |
| Jun 17, 2026 | Sullivan Mark J. Director | Option exercise | 27,050 | $0 |
| Jun 17, 2026 | Shapiro Richard A Director | Option exercise | 27,050 | $0 |
| Jun 17, 2026 | Glat Neil Director | Option exercise | 27,050 | $0 |
| Jun 17, 2026 | Mounts Gonzales David Director | Option exercise | 27,050 | $0 |
| Jun 15, 2026 | Ellenbogen Michael Director | Option exercise 10b5-1 plan | 80,745 | $19.4K |
| Jun 15, 2026 | Ellenbogen Michael Director | Sale 10b5-1 plan | 80,745 | $501.4K |
| Jun 2, 2026 | Marshall Robert E Chief Revenue Officer | Sale | 62,067 | $425.2K |
| Jun 1, 2026 | Marshall Robert E Chief Revenue Officer | Option exercise | 136,363 | $0 |
| May 15, 2026 | Ellenbogen Michael Director | Sale 10b5-1 plan | 80,745 | $454.6K |
| May 15, 2026 | Ellenbogen Michael Director | Option exercise 10b5-1 plan | 80,745 | $19.4K |
| May 4, 2026 | Kutsor George C Chief Financial Officer | Sale | 51,448 | $374.0K |
| May 1, 2026 | Kutsor George C Chief Financial Officer | Option exercise | 138,888 | $0 |
| Apr 15, 2026 | Ellenbogen Michael Director | Option exercise 10b5-1 plan | 80,745 | $19.4K |
| Apr 15, 2026 | Ellenbogen Michael Director | Sale 10b5-1 plan | 80,745 | $510.3K |
| Mar 6, 2026 | Ellenbogen Michael Director | Sale 10b5-1 plan | 91,771 | $468.0K |
| Mar 2, 2026 | Ellenbogen Michael Director | Sale | 82,913 | $430.3K |
| Mar 2, 2026 | Chitkara Anil Founder & Chief Growth Officer | Sale | 63,670 | $330.4K |
| Mar 1, 2026 | Ellenbogen Michael Director | Option exercise | 66,787 | $0 |
| Mar 1, 2026 | Chitkara Anil Founder & Chief Growth Officer | Option exercise | 53,430 | $0 |
| Mar 1, 2026 | Chitkara Anil Founder & Chief Growth Officer | Option exercise | 45,913 | $0 |
| Mar 1, 2026 | Chitkara Anil Founder & Chief Growth Officer | Option exercise | 37,878 | $0 |
| Mar 1, 2026 | Ellenbogen Michael Director | Option exercise | 57,392 | $0 |
| Mar 1, 2026 | Ellenbogen Michael Director | Option exercise | 50,505 | $0 |
| Feb 17, 2026 | Ellenbogen Michael Director | Sale 10b5-1 plan | 80,745 | $441.7K |
| Feb 17, 2026 | Ellenbogen Michael Director | Option exercise 10b5-1 plan | 80,745 | $19.4K |
| Jan 16, 2026 | Ellenbogen Michael Director | Option exercise 10b5-1 plan | 80,745 | $19.4K |
| Jan 16, 2026 | Ellenbogen Michael Director | Sale 10b5-1 plan | 80,745 | $500.6K |
| Jan 5, 2026 | Kedzierski John President & CEO | Sale | 74,322 | $522.5K |
| Jan 2, 2026 | Kedzierski John President & CEO | Option exercise | 207,000 | $0 |
| Dec 31, 2025 | Sullivan Mark J. Director | Option exercise | 7,575 | $0 |
| Dec 15, 2025 | Ellenbogen Michael Director | Sale 10b5-1 plan | 80,745 | $557.9K |
| Dec 15, 2025 | Ellenbogen Michael Director | Option exercise 10b5-1 plan | 80,745 | $19.4K |
| Nov 25, 2025 | Marshall Robert E Chief Revenue Officer | Purchase | 7,000 | $42.4K |
| Nov 21, 2025 | Kedzierski John President & CEO | Purchase | 8,000 | $47.3K |
Source: SEC Form 4 filings. Form 4 reports transactions, not the cap table — absence of filings says nothing about how much an insider owns, and a quiet window is not a signal.
Your own record
Start an Inve Case for Evolv Technologies Holdings, Inc.
Free account. Everything above stays public.
Write why you follow Evolv Technologies Holdings, Inc. and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading